Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Bolsters position in pharmaceutical products testing
January 13, 2016
By: Tim Wright
Editor-in-Chief, Contract Pharma
Eurofins Scientific has acquired Sinensis Life Sciences BV, a provider of pharmaceutical product testing and cGMP quality control (QC) services in the Netherlands. Sinensis has a strong position in both microbiology and chemistry testing for biopharmaceutical products in the domestic market, and has a presence in Europe, Asia and the U.S. The company employs about 150 staff, serving the pharmaceutical and biotechnology industries throughout the Netherlands. Since inception, Sinensis says it has consistently grown above Eurofins’ annual organic growth objective, and expects to generate revenues in excess of €13.5 million for 2015, the majority of which from biopharmaceutical products testing. The company is also active in biosafety testing and biological R&D, chemical R&D, and in cGMP manufacturing. Sinensis’ competencies are consistent with Eurofins’ biopharmaceutical testing capabilities, and specifically with the competencies of Eurofins Lancaster. The acquisition strengthens the group’s geographical footprint and its position as a market leader in this growing pharmaceutical services segment. The acquisition also reinforces the group’s platform to further accelerate the deployment of the most advanced testing methodologies to support the pharmaceutical and biotechnology industries across the entire drug development cycle in Europe. “The acquisition of Sinensis further strengthens Eurofins’ global leadership in the rapidly-growing pharmaceutical products testing market,” said Gilles Martin, chief executive officer, Eurofins. “We look forward to strengthening Sinensis’ testing portfolio and operating footprint by providing access to the full range of services and capabilities of the Eurofins Group.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !